Epidemiology and Management of Metastatic Breast Cancer
NCT01711502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2014-01-30
Summary
This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.
Conditions
- Breast Cancer Nos Metastatic Recurrent
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Dediu Mrcea, SENIOR PHYSICIAN · Bucharest Institute of Oncology
-
Alexandru Eniu, SENIOR PHYSICIAN · Cluj Institute of Oncology
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Romania
Study Locations
More Related Trials
-
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.
NCT00448591 ·Status: COMPLETED ·Phase: PHASE3
-
Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer
NCT01745757 ·Status: COMPLETED
-
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
NCT02028507 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
NCT02819882 ·Status: RECRUITING
-
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
NCT02860585 ·Status: COMPLETED
-
Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer
NCT01978977 ·Status: COMPLETED
-
Brain Metastasis in Breast Cancer Patients
NCT01077648 ·Status: COMPLETED
-
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
NCT03275311 ·Status: RECRUITING
-
Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients
NCT01782651 ·Status: COMPLETED
-
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
NCT01702571 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
NCT03205761 ·Status: COMPLETED ·Phase: PHASE2
-
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
NCT01373710 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer
NCT01094184 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.
NCT06839547 ·Status: NOT_YET_RECRUITING
-
Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer
NCT04370522 ·Status: TERMINATED
-
Personalised Disease Monitoring in Metastatic Breast Cancer
NCT04597580 ·Status: ACTIVE_NOT_RECRUITING
-
BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment
NCT03789019 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
NCT00333775 ·Status: COMPLETED ·Phase: PHASE3
-
BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
NCT00540800 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer
NCT01300962 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
NCT03355157 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
NCT00240071 ·Status: COMPLETED ·Phase: PHASE2
-
Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors
NCT01218529 ·Status: COMPLETED ·Phase: PHASE2
-
Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer
NCT00503906 ·Status: COMPLETED ·Phase: PHASE2
-
To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
NCT03286842 ·Status: COMPLETED ·Phase: PHASE3